News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
European Biopharma Sector Gears Up for Major Innovation Conference in Berlin
Tuesday, October 03, 2023
Breakthrough in mRNA Vaccine Development Announced by European Consortium
Tuesday, October 03, 2023
Alzamend Neuro Granted FDA Authorization for Phase IIA Clinical Trial of AL001, an Innovative Lithium-based Therapeutic, in Bipolar Disorder Patients
Monday, October 02, 2023Alzamend Neuro Inc Nasdaq ALZN has received a positive response from the US Food and Drug Administration FDA to proceed with their Phase IIA clinical study designated as ALBD for Bipolar Disorder type
Tradeup Acquisition Corp. And Estrella Biopharma, Inc. Announce the Successful Completion of Their Business Combination
Saturday, September 30, 2023Estrella Immunopharma Inc formerly known as TradeUP Acquisition Corp NASDAQ UPTD UPTDW UPTDU has successfully completed its merger with Estrella Biopharma Inc a preclinicalstage biopharmaceutical company specializing in Tcell therapies for blood canc...
Northx Biologics AB Commences Operations at Matfors Facility's New Innovation Hub
Friday, September 29, 2023NorthX Biologics AB is excited to announce the official opening of its advanced Innovation Hub located at the Matfors facility
Immunogenesis Initiates Phase 1a/1b Clinical Trial for IMGS-001 in Patients With Advanced Solid Tumors Who Have Relapsed or Are Refractory
Friday, September 29, 2023ImmunoGenesis has recently announced the initiation of its Phase ab clinical trial for its lead candidate IMGS at The University of Texas MD Anderson Cancer Center in Houston Texas
Merck KGaA, Darmstadt, Germany and Quris-ai Enhance Their Collaboration
Friday, September 29, 2023QurisAI an innovative player in the pharmaceutical industry powered by artificial intelligence AI has announced the expansion of its collaboration with Merck KGaA Darmstadt Germany a prominent science and technology company
GenSight Biologics Issues Update Regarding Scientific Advice from the European Medicines Agency for LUMEVOQ®
Thursday, September 28, 2023GenSight Biologics Euronext SIGHT ISIN FR PEAPME eligible has provided an update regarding its discussions with the European Medicines Agency EMA on the design of a new Phase III trial for LUMEVOQ
Pathios Therapeutics Granted Funding by Innovate UK to Assess Novel Immunotherapy Approach in Malignant Brain Cancer Models
Thursday, September 28, 2023Pathios Therapeutics Limited a biotechnology company dedicated to advancing innovative cancer therapies has been awarded a grant of equivalent to approximately US from Innovate UK
Commencement of Immunotherapy Dosing for Leukemia Patients in Phase I/II Trial of ProTcell Therapy SMART101 in ReSET-02
Thursday, September 28, 2023Smart Immune a clinicalstage biotechnology company focusing on the development of ProTcell a Tcell progenitor therapy platform designed to swiftly rejuvenate the immune system has officially initiated its ReSET Phase III trial for adult acute leukemi...
